Glaxosmithkline LLC

Smithkline Beecham Corporation

Lilly Icos LLC

Romain Luc Marie Gosmini

Olivier Mirguet

Jason Scott Sawyer

Mark W Orme

Alain Claude-Marie Daugan

Emmanuel Hubert Demont

Rodolfo Cadilla

Jason Witherington

Millard Hurst Lambert, Iii

Michael Lawrence Sierra

James Bailey

Paul John Beswick

David Matthew Wilson

Jonathan Thomas Seal

Vipulkumar Kantibhai Patel

Nigel Paul King

Lisa M Schultze

Neil Stuart Garton

Thomas George Christopher Hayhow

Michael David Woodrow

Françoise Jeanne Gellibert

Richard Bell

Richard Martin Grimes

Christopher Charles Frederick Hamlett

Benzodiazepine compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.

Benzodiazepine bromodomain inhibitor

The present invention relates to a benzodiazepine compound of formula (I), processes for its preparation, pharmaceutical compositions containing such a compound and to its use in therapy. 

Tetrahydroquinoline compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and their use in therapy.

Tetrahydroquinoline derivatives and their pharmaceutical use

Tetrahydroquinoline compounds of formula (I) or a salt thereof, pharmaceutical compositions containing such compounds and their use in therapy, in particular in the treatment of diseases or conditions for which a bromodomain inhibitor is indicted.

Thetrahydroquinolines derivatives as bromodomain inhibitors

The present invention provides combinations of compounds of formula (I) and other therapeutic agents for the treatment of PPAR related diseases. 

Thiazole derivatives for treating PPAR related disorders

A compound of formula (I) or a pharmaceutically acceptable salt, solvate, or hydrolysable ester thereof, wherein: 

Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hPPAR activators

The present invention provides compounds of formula (I). These compounds are used for the treatment of PPAR related diseases

Compounds of general structural formula (I), and use of the compounds or salts or solvates thereof as therapeutic agents, are disclosed

Condensed pyridoindole derivatives

Compounds of the general structural formula and use of the compounds and salts and solvates thereof, as therapeutic agents.

Growing community of inventors

Les Ulis, France

Romain Luc Marie Gosmini